BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11136578)

  • 1. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.
    Kim YT; Rha SY; Shim CY; Sohn JH; Kim C; Yu NC; Chung HC; Kim JH; Han DS; Kim BS; Roh JK
    Yonsei Med J; 2003 Jun; 44(3):539-43. PubMed ID: 12833596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer: PCD and brain metastases.
    Stepanić V; Matković V; Corusić A; Barisić D; Buković D; Ilić-Forko J
    Coll Antropol; 2007 Jun; 31(2):633-6. PubMed ID: 17847951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
    Santillan A; Bristow RE
    Nat Clin Pract Oncol; 2006 Feb; 3(2):108-12; quiz 1 p following 112. PubMed ID: 16462852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotic syndrome as a paraneoplastic symptom of Hodgkin's disease in two children].
    Raphaël MF; Groothoff JW; van den Berg H
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1595-8. PubMed ID: 12224484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
    Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
    J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
    Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
    J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome antibodies in paraneoplastic cerebellar degeneration.
    Storstein A; Knudsen A; Vedeler CA
    J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
    Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
    Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Denny-Brown sensory neuropathy disclosing a bilateral ovarian adenocarcinoma].
    Humbert P; Mas J; Monnier G; Carbillet JP; Chatelain F; Montcuquet P; Dupond JL
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):723-6. PubMed ID: 3206097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of the tumor marker CA-125 after oophorectomy in a patient with paraneoplastic cerebellar degeneration without detectable cancer.
    Mason WP; Dalmau J; Curtin JP; Posner JB
    Gynecol Oncol; 1997 Apr; 65(1):173-6. PubMed ID: 9103409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
    Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
    Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
    Lin JT; Lachmann E; Nagler W
    J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unspecific increase of tumor markers in a girl with nephrotic syndrome and ovarian teratoma.
    Kilis-Pstrusinska K; Szajerka U; Zwolinska D
    Ren Fail; 2013; 35(5):654-6. PubMed ID: 23560847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
    David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
    Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
    Saeed DB; Gupta L
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.